Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZeniABSORB
- Development stage
- Unknown
- Lead developer
- Focus Health Group
- Administration
- Topical
01
Overview
ZeniABSORB is a sterile, super absorbent wound dressing developed and marketed by Focus Health Group for the management of heavily draining or exuding wounds. The product features a multi-layered construction, including a silicone non-adherent contact layer, a hydro-penetrating layer, and a core containing super absorbent polymers (SAPs) that bind fluid and convert it into a gel. This design facilitates fluid management, maintains an optimal moist wound environment, and protects against maceration while being gentle on sensitive and fragile skin. It is commercially available as a primary or secondary dressing in various sizes and is distributed through medical wholesalers such as McKesson.
- Brand names
- ZeniABSORB
Beyond the preview
Go deeper on ZeniABSORB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZeniABSORB.